ADPT Operating Cash Flow (Statement)
Adaptive Biotechnologies Corp · Operating Cash Flow (Statement)
ADPT Operating Cash Flow (Statement)
Latest reported-$21.01Mperiod ending
ADPT TTM Cash from Operations (-$32.26M → -$21.01M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ADPT operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -21,009,000 | |
| -27,039,000 | |
| -45,986,000 | |
| -60,532,000 | |
| -80,470,000 | |
| -85,343,000 | |
| -95,212,000 | |
| -109,653,000 | |
| -129,272,000 | |
| -135,525,000 | |
| -156,324,000 | |
| -159,411,000 | |
| -155,135,000 | |
| -178,644,000 | |
| -183,945,000 | |
| -207,752,000 | |
| -208,787,000 | |
| -198,935,000 | |
| -192,727,000 | |
| -178,745,000 | |
| -182,458,000 | |
| -176,322,000 | |
| -149,683,000 | |
| -136,630,000 | |
| -119,612,000 | |
| -104,505,000 | |
| 205,404,000 | |
| 226,785,000 | |
| 245,237,000 | |
| 252,141,000 | |
| -32,259,000 |